Back to Search Start Over

1300P Exploration of a novel HRD signature (HRDsig) as a biomarker of first line FOLFIRINOX benefit in metastatic pancreatic cancer

Authors :
A. Singhi
T. Chen
R.W. Madison
N. Bhardwaj
D.X. Jin
Z. Fleischmann
J. Newberg
J. Moore
G.M. Frampton
P. Hegde
D.A. Fabrizio
J. He
A.B. Schrock
E. Ebot
E.S. Sokol
Source :
Annals of Oncology. 33:S1138
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........36942071e56492a33fe678169a362548
Full Text :
https://doi.org/10.1016/j.annonc.2022.07.1432
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details